Literature DB >> 27621492

Possible Atazanavir-Induced Cholelithiasis in a Pregnant Woman: A Case Report.

Claire Bianchi1, Kateri Lévesque2, Marc Boucher3, Ema Ferreira4.   

Abstract

Entities:  

Year:  2016        PMID: 27621492      PMCID: PMC5008428          DOI: 10.4212/cjhp.v69i4.1582

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


× No keyword cloud information.
  10 in total

Review 1.  Drug-induced cholestasis.

Authors:  S Erlinger
Journal:  J Hepatol       Date:  1997       Impact factor: 25.083

2.  Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.

Authors:  Eve Courbon; François Laylavoix; Cathia Soulié; Christine Le Beller; Vincent Calvez; Christine Katlama; Gilles Peytavin
Journal:  J Antimicrob Chemother       Date:  2011-10-23       Impact factor: 5.790

3.  Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.

Authors:  Tim O Lankisch; Ulrike Moebius; Michael Wehmeier; Georg Behrens; Michael P Manns; Reinhold E Schmidt; Christian P Strassburg
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Complicated atazanavir-associated cholelithiasis: a report of 14 cases.

Authors:  Soloniaina Rakotondravelo; Yves Poinsignon; Françoise Borsa-Lebas; Arnaud de la Blanchardière; Christophe Michau; Hélène Jantzem; Nathalie Massy; Elisabeth Polard; Fanny Giroux; Hélène Kerspern; Ahmed Meskar; Guy Hue; Olivier Tribut; Cédric Arvieux; Pierre Tattevin
Journal:  Clin Infect Dis       Date:  2012-07-19       Impact factor: 9.079

6.  Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus.

Authors:  Renaud Verdon; Michel Daudon; Françoise Albessard; Jean-Louis Brefort; Claude Bazin
Journal:  Clin Infect Dis       Date:  2002-08-06       Impact factor: 9.079

7.  Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult.

Authors:  Amanda Caroline Jacques; Pierre Giguère; Guijun Zhang; Claire Touchie; Charles J L la Porte
Journal:  Ann Pharmacother       Date:  2009-12-02       Impact factor: 3.154

8.  A population study on the prevalence of gallstone disease: the Sirmione Study.

Authors:  L Barbara; C Sama; A M Morselli Labate; F Taroni; A G Rusticali; D Festi; C Sapio; E Roda; C Banterle; A Puci
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

9.  Cumulative exposure to ritonavir-boosted atazanavir is associated with cholelithiasis in patients with HIV-1 infection.

Authors:  Takeshi Nishijima; Takuro Shimbo; Hirokazu Komatsu; Yohei Hamada; Hiroyuki Gatanaga; Yoshimi Kikuchi; Shinichi Oka
Journal:  J Antimicrob Chemother       Date:  2013-12-29       Impact factor: 5.790

10.  Is ritonavir-boosted atazanavir a risk for cholelithiasis compared to other protease inhibitors?

Authors:  Yohei Hamada; Takeshi Nishijima; Hirokazu Komatsu; Katsuji Teruya; Hiroyuki Gatanaga; Yoshimi Kikuchi; Shinichi Oka
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.